William G. Wierda, M.D., Ph.D., medical director of the Leukemia Center at The University of Texas MD Anderson Cancer Center, discusses how to best combine and sequence therapies for patients with chronic lymphocytic leukemia (CLL).
William G. Wierda, M.D., Ph.D.
Advertisement
Articles by William G. Wierda, M.D., Ph.D.
Advertisement
Latest Updated Articles
Combining and Sequencing Agents in CLLPublished: January 30th 2018 | Updated:
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Fast Track Designation to ADCE-D01 for Soft Tissue Sarcoma
2
Finding Hope Amidst a Lung Cancer Diagnosis
3
What Newly Diagnosed Patients Need to Know About Stage 2 Melanoma
4
Understanding Sarcoma: Types, Treatment and Living Well
5
